Skip to main content
Clinical Trials/NCT00997113
NCT00997113
Completed
Phase 4

Physiologic Stress During Procedural Sedation With and Without Alfentanil

Hennepin Healthcare Research Institute1 site in 1 country20 target enrollmentOctober 2009

Overview

Phase
Phase 4
Intervention
propofol
Conditions
Sedation
Sponsor
Hennepin Healthcare Research Institute
Enrollment
20
Locations
1
Primary Endpoint
Change in Serum Catecholamines
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

This is a randomized clinical trial of deep procedural sedation with propofol with and without supplemental alfentanil. Patients will be assessed for total and fractionated serum catecholamines before and after the procedure in addition to usual procedural sedation outcomes parameters to assess the adrenergic effect of propofol sedation without supplemental opioid.

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
December 2012
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients who will require deep procedural sedation with propofol in the ED

Exclusion Criteria

  • intoxication
  • unable to provide informed consent
  • allergy to propofol or alfentanil
  • ASA physical status score \> 2

Arms & Interventions

Propofol

propofol only for deep procedural sedation

Intervention: propofol

Propofol/alfentanil

Propofol with alfentanil for deep procedural sedation

Intervention: propofol

Propofol/alfentanil

Propofol with alfentanil for deep procedural sedation

Intervention: alfentanil

Outcomes

Primary Outcomes

Change in Serum Catecholamines

Time Frame: one minute prior to the start of the procedure and immediately at the end of sedation procedure (median time of procedure 12 minutes range 6-26 minutes

change in serum catecholamine levels, values indicate a decrease over the procedure. These patients underwent fracture reduction procedures which are typically associated with an increase in catecholamines.

Secondary Outcomes

  • Respiratory Depression(From one minute prior to the start of the sedation procedure until the patient has returned to baseline mental status)
  • Patient Reported Pain and Recall of the Painful Procedure for Which They Were Sedated Measure by Patient Query After They Had Regained Their Baseline Level of Consciousness After the Procedure(single time point measured after sedation procedure completed)

Study Sites (1)

Loading locations...

Similar Trials